Charles M. Winter - 01 Jan 2023 Form 3/A - Amendment Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Chief Technical Officer
Signature
/s/ James Pennington, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3/A - Amendment
Filing time
03 Jan 2025, 20:01:19 UTC
Date Of Original Report
05 Jan 2023
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JANX Common Stock 46,111 01 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the Reporting Person's original Form 3, and also were omitted from two Forms 4 filed by the Reporting Person after his original Form 3 was filed.